Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

EUR/USD

1.1788

-0.0048

-0.40%

GBP/USD

1.3429

0.0019

0.14%

USD/JPY

112.25

-0.4785

-0.42%

USD/CHF

0.9876

0.0022

0.22%

EUR/GBP

0.8778

-0.0048

-0.55%

USD/CAD

1.2753

-0.0064

-0.50%

NZD/USD

0.6989

-0.0030

-0.42%

EUR/JPY

132.32

-1.1050

-0.83%

EUR/CHF

1.1642

-0.0022

-0.19%

ENDRA Life Sciences Inc.

NASDAQ: NDRA / / -
4.50+0.25+5.88%Vol 33 4841Y Perf -4.87%
Dec 14th, 2017 15:15
BID4.40 ASK4.63
Open4.02 Previous Close4.25
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)18 
Earnings Rating
Price Range Ratio 52wk %
85.77 
Earnings Date

Today's Price Range

4.024.89

 

52wk Range

2.154.89

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
80.85%
3 Months
63.46%
6 Months
-
1 Year
-4.87%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
NDRA4.500.25005.88
AAPL172.320.05000.03
GOOG1 048.658.04000.77
MSFT84.88-0.4700-0.55
XOM83.04-0.0800-0.10
WFC59.460.06000.10
JNJ142.01-0.8800-0.62
FB178.770.47000.26
GE17.67-0.0900-0.51
JPM104.91-0.6000-0.57
...

TickerPriceChg.%52 Week High
FOXA34.846.3835.15
FOX34.165.6334.35
MAT16.364.9431.60
TIF99.443.48100.80
DIS110.913.07116.10
DAL55.182.8955.75
STZ223.572.28227.20
WMB29.712.2432.69
EQIX459.801.89495.35
MCK157.871.71169.29
CMCSA39.221.6642.18
CBS58.111.6470.10
COP52.521.6354.22
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 22.40
Current Ratio 23.10
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -4.00
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin52.90
EBIT Margin-307.10
EBITDA Margin-299.90
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.96
PS Ratios 16.30
Price to Cash Flow -
Price to Free Cash Flow -7.50
Cash Flow Per Share -0.63
Price to Tangible Book1.96
Book Value per Share1.83
Enterprise Value (in ths.)7 088
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -108.89
Return on Assets (5Y Avg) -
ROA last 12 Months -92.51
Return on Capital (5Y Avg) -
ROC last 12 Months -100.72
Return on invested Capital Q -12.13
Return on invested Capital Y-
Assets Turnover0.20
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)860
Revenue per Share 0.22
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume33 484
Shares Outstanding (in ths.)3 910
Trades Count101
Dollar Volume192 083
Avg. Volume9 013
Avg. Weekly Volume32 265
Avg. Monthly Volume20 476
Avg. Quarterly Volume11 902

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x